Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Buy Out

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon May 31, 2021 12:46pm

215 Views

Post# 33296502

RE:Buy Out

When you are putting out 1 NR per year, I think you have some cycles to work another job. I hope Sernova isn't paying him what MRS is. Don't hold your breath for a buyout. Short of a potential deal, everything else is already baked into the price. Unusual uptick on low volume today. Maybe we can blame the americans for keeping down the stock price.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec